These results suggest that febuxostat may directly act on osteoclastic lineage cells and also impair RANKL expression in bone marrow stromal cells to suppress osteoclastogenesis in cocultures of MM cells with bone marrow cells. The gene discussed is TNFSF11; the disease is Miyoshi myopathy.